ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,339Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1383

$1.24M Total Retail Price of All Prescriptions

Rank: 32 out of 1383

577 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Tennessee
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 577 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 577 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 695 648 101 1 7
LEVOTHYROXINE SODIUM 688 616 105 2 1
HYDROCODONE-ACETAMINOPHEN 612 534 98 S3 3 2
OMEPRAZOLE 576 516 104 4 5
POTASSIUM CHLORIDE 570 547 93 5 13
LISINOPRIL 522 487 85 6 3
SIMVASTATIN 468 456 85 7 4
CLOPIDOGREL 437 432* 46 8 17
NAMENDA 415 415 34 9 41
ESCITALOPRAM OXALATE 401 396* 48 10 57
GABAPENTIN 377 357 51 11 10
MELOXICAM 318 273 61 12 21
AMLODIPINE BESYLATE 317 312* 51 13 6
METFORMIN HCL 314 286 48 14 8
ATORVASTATIN CALCIUM 300 271 57 15 11
LORAZEPAM 283 261 46 B 16 25
CITALOPRAM HBR 281 276* 44 17 18
METOPROLOL TARTRATE 252 247* 36 18 9
ZOLPIDEM TARTRATE 249 228 52 19 27
CARVEDILOL 230 211 30 20 24
CYMBALTA 229 167 27 21 46
ALPRAZOLAM 225 204 45 B 22 12
TRAMADOL HCL 219 205 27 23 28
BISOPROLOL-HYDROCHLOROTHIAZIDE 215 187 35 24 151
PANTOPRAZOLE SODIUM 210 190 39 25 26
POLYETHYLENE GLYCOL 3350 205 200* 51 26 67
WARFARIN SODIUM 204 204 25 27 16
PRAVASTATIN SODIUM 198 181 37 28 15
SERTRALINE HCL 191 186* 27 29 22
TAMSULOSIN HCL 179 174* 36 30 32
RANITIDINE HCL 177 164 33 31 23
LYRICA 167 131 18 32 73
ALLOPURINOL 163 151 27 33 36
DONEPEZIL HCL 161 161 16 34 39
RISPERIDONE 156 156 11 A 35 75
BUSPIRONE HCL 153 153 14 36 98
METFORMIN HCL ER 151 128 34 37 47
FENOFIBRATE* 146 129 33 38 63
DIGOXIN 145 140* 14 39 138
EXELON 140 140 24 40 109
ATENOLOL 135 117 14 41 19
TRAZODONE HCL 133 128* 19 42 37
QUETIAPINE FUMARATE 132 127* 23 A 43 55
CLONIDINE HCL 130 130 17 44 50
DIVALPROEX SODIUM 128 109 16 45 74
GALANTAMINE HBR 126 121* 12 46 241
FELODIPINE ER 123 118* 18 47 265
HYDROCHLOROTHIAZIDE 119 98 26 48 14
NITROFURANTOIN* 112 107* 28 49 183
ZETIA 110 105* 18 50 95
FLUOXETINE HCL 109 104* 13 51 54
LOSARTAN POTASSIUM 108 103* 26 52 20
DILTIAZEM ER 103 <11 <11 53 127
CILOSTAZOL 101 96* 12 54 228
PAROXETINE HCL 98 <11 <11 55 58
ROPINIROLE HCL 96 84 11 56 81
LOVAZA 96 68 15 56 233
PREMARIN 93 79 24 R 58 141
MIRTAZAPINE 92 87* 18 59 49
LANTUS 92 81 16 59 60
VICTOZA 3-PAK 91 69 23 61 270
CARBIDOPA-LEVODOPA 91 86* 11 61 114
CHLORTHALIDONE 89 84* 13 63 158
MECLIZINE HCL 89 84* 23 63 111
CRESTOR 87 82* 17 65 40
ISOSORBIDE MONONITRATE ER 87 87 14 65 69
DEXILANT 85 73 19 67 121
CEPHALEXIN 82 77* 57 68 91
GEMFIBROZIL 81 76* 16 69 94
LEVOCETIRIZINE DIHYDROCHLORIDE 80 75* 23 70 176
VENLAFAXINE HCL ER 79 74* 11 71 92
TRIAMTERENE-HCTZ 78 73* 15 72 53
AMOX TR-POTASSIUM CLAVULANATE 78 63 64 72 104
DIOVAN 76 76 11 74 64
PREDNISONE 76 71* 19 74 44
CIPROFLOXACIN HCL 75 64 63 76 59
CYCLOBENZAPRINE HCL 73 50 26 R 77 82
GLYBURIDE MICRONIZED 72 67* 17 R 78 274
LEVOFLOXACIN 72 67* 51 78 76
LANSOPRAZOLE 72 67* 19 78 179
MEGESTROL ACETATE 70 65* 22 R 81 185
SPIRONOLACTONE 69 57 11 82 68
NITROGLYCERIN PATCH 69 <11 <11 82 189
LOVASTATIN 65 60* 11 84 31
FAMOTIDINE* 65 65 13 84 61
VALSARTAN-HYDROCHLOROTHIAZIDE 65 65 13 84 106
GLIPIZIDE 64 64 11 87 77
TERAZOSIN HCL 64 <11 <11 87 131
VESICARE 64 <11 <11 87 124
AGGRENOX 62 <11 <11 90 217
PROAIR HFA 61 44 24 91 35
AMOXICILLIN 61 56* 50 91 116
MONTELUKAST SODIUM 59 54* 12 93 43
PRISTIQ ER 59 <11 <11 93 358
CARAFATE 58 <11 <11 95 331
FLUCONAZOLE 58 45 36 95 134
TEMAZEPAM 58 41 15 B 95 110
QUINAPRIL HCL 58 <11 <11 95 159
AVODART 57 <11 <11 99 238
AZITHROMYCIN 56 45 46 100 52
DICYCLOMINE HCL 56 <11 <11 100 172
SYNTHROID 56 51* 13 100 78
GLIMEPIRIDE 54 49* 13 103 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 49* 38 103 89
METHOTREXATE 54 <11 <11 103 247
ACETAMINOPHEN-CODEINE 53 <11 <11 S3 106 173
BETHANECHOL CHLORIDE 53 <11 <11 106 399
LEVEMIR 53 48* 12 106 137
NEXIUM 52 34 15 109 29
BENAZEPRIL HCL 52 <11 <11 109 45
METOCLOPRAMIDE HCL 52 <11 <11 109 125
MUPIROCIN* 51 51 23 112 175
SPIRIVA 51 51 13 112 51
RAMIPRIL 50 <11 <11 114 87
ENALAPRIL MALEATE 50 <11 <11 114 85
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.